Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season

Ji Yun Noh; Sooyeon Lim; Joon Young Song; Won Suk Choi; Hye Won Jeong; Jung Yeon Heo; Jacob Lee; Yu Bin Seo; Jin Soo Lee; Seong Heon Wie; Young Keun Kim; Kyung Hwa Park; Sook In Jung; Shin Woo Kim; Sun Hee Lee; Han Sol Lee; Young Hoon Yoon; Hee Jin Cheong; Woo Joo Kim

doi:10.1371/journal.pone.0178010

Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season

Ji Yun Noh, Sooyeon Lim, Joon Young Song, Won Suk Choi, Hye Won Jeong, Jung Yeon Heo, Jacob Lee, Yu Bin Seo, Jin Soo Lee, Seong Heon Wie, Young Keun Kim, Kyung Hwa Park, Sook In Jung, Shin Woo Kim, Sun Hee Lee, Han Sol Lee, Young Hoon Yoon, Hee Jin Cheong, Woo Joo Kim

Internal Medicine

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

In the 2016-2017 season, the A(H3N2) influenza epidemic presented an unusual early peak pattern compared with past seasons in South Korea. The interim vaccine effectiveness (VE) of influenza vaccination in preventing laboratory-confirmed influenza was estimated using test-negative design through the tertiary hospital-based influenza surveillance system in South Korea. From 1 September, 2016 to 7 January, 2017, adjusted VE of influenza vaccination in preventing laboratory-confirmed A(H3N2) was -52.1% (95% confidence interval [CI], -147.2 to 6.4); -70.0% (95% CI, -212.0 to 7.4) in 19-64 years and 4.3% (95% CI, -137.8 to 61.5) in the elderly. Circulating A(H3N2) viruses belonged to the three phylogenetic subclades of 3C.2a, differently to A/Hong Kong/4801/2014, the current vaccine strain. Amino acid substitutions in hemagglutinin of circulating viruses seem to contribute to low VE. In conclusion, interim VE analysis presented that the protection of laboratory-confirmed influenza by seasonal influenza vaccination did not show the statistical significance in South Korea in the 2016-2017 influenza season.

Original language	English
Article number	e0178010
Journal	PloS one
Volume	12
Issue number	5
DOIs	https://doi.org/10.1371/journal.pone.0178010
Publication status	Published - 2017 May

Bibliographical note

Funding Information:
This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001) and by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (NRF- 2016R1A5A1010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

All Science Journal Classification (ASJC) codes

Biochemistry, Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)
General

Access to Document

10.1371/journal.pone.0178010

Fingerprint Dive into the research topics of 'Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season'. Together they form a unique fingerprint.

Cite this

Noh, J. Y., Lim, S., Song, J. Y., Choi, W. S., Jeong, H. W., Heo, J. Y., Lee, J., Seo, Y. B., Lee, J. S., Wie, S. H., Kim, Y. K., Park, K. H., Jung, S. I., Kim, S. W., Lee, S. H., Lee, H. S., Yoon, Y. H., Cheong, H. J., & Kim, W. J. (2017). Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season. PloS one, 12(5), [e0178010]. https://doi.org/10.1371/journal.pone.0178010

Noh, Ji Yun ; Lim, Sooyeon ; Song, Joon Young ; Choi, Won Suk ; Jeong, Hye Won ; Heo, Jung Yeon ; Lee, Jacob ; Seo, Yu Bin ; Lee, Jin Soo ; Wie, Seong Heon ; Kim, Young Keun ; Park, Kyung Hwa ; Jung, Sook In ; Kim, Shin Woo ; Lee, Sun Hee ; Lee, Han Sol ; Yoon, Young Hoon ; Cheong, Hee Jin ; Kim, Woo Joo. / Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season. In: PloS one. 2017 ; Vol. 12, No. 5.

@article{39ff2d0e69944d64995f12e263150f2e,

title = "Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season",

abstract = "In the 2016-2017 season, the A(H3N2) influenza epidemic presented an unusual early peak pattern compared with past seasons in South Korea. The interim vaccine effectiveness (VE) of influenza vaccination in preventing laboratory-confirmed influenza was estimated using test-negative design through the tertiary hospital-based influenza surveillance system in South Korea. From 1 September, 2016 to 7 January, 2017, adjusted VE of influenza vaccination in preventing laboratory-confirmed A(H3N2) was -52.1% (95% confidence interval [CI], -147.2 to 6.4); -70.0% (95% CI, -212.0 to 7.4) in 19-64 years and 4.3% (95% CI, -137.8 to 61.5) in the elderly. Circulating A(H3N2) viruses belonged to the three phylogenetic subclades of 3C.2a, differently to A/Hong Kong/4801/2014, the current vaccine strain. Amino acid substitutions in hemagglutinin of circulating viruses seem to contribute to low VE. In conclusion, interim VE analysis presented that the protection of laboratory-confirmed influenza by seasonal influenza vaccination did not show the statistical significance in South Korea in the 2016-2017 influenza season.",

author = "Noh, {Ji Yun} and Sooyeon Lim and Song, {Joon Young} and Choi, {Won Suk} and Jeong, {Hye Won} and Heo, {Jung Yeon} and Jacob Lee and Seo, {Yu Bin} and Lee, {Jin Soo} and Wie, {Seong Heon} and Kim, {Young Keun} and Park, {Kyung Hwa} and Jung, {Sook In} and Kim, {Shin Woo} and Lee, {Sun Hee} and Lee, {Han Sol} and Yoon, {Young Hoon} and Cheong, {Hee Jin} and Kim, {Woo Joo}",

note = "Funding Information: This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001) and by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (NRF- 2016R1A5A1010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",

year = "2017",

month = may,

doi = "10.1371/journal.pone.0178010",

language = "English",

volume = "12",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "5",

}

Noh, JY, Lim, S, Song, JY, Choi, WS, Jeong, HW, Heo, JY, Lee, J, Seo, YB, Lee, JS, Wie, SH, Kim, YK, Park, KH, Jung, SI, Kim, SW, Lee, SH, Lee, HS, Yoon, YH, Cheong, HJ & Kim, WJ 2017, 'Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season', PloS one, vol. 12, no. 5, e0178010. https://doi.org/10.1371/journal.pone.0178010

Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season. / Noh, Ji Yun; Lim, Sooyeon; Song, Joon Young; Choi, Won Suk; Jeong, Hye Won; Heo, Jung Yeon; Lee, Jacob; Seo, Yu Bin; Lee, Jin Soo; Wie, Seong Heon; Kim, Young Keun; Park, Kyung Hwa; Jung, Sook In; Kim, Shin Woo; Lee, Sun Hee; Lee, Han Sol; Yoon, Young Hoon; Cheong, Hee Jin; Kim, Woo Joo.

In: PloS one, Vol. 12, No. 5, e0178010, 05.2017.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season

AU - Noh, Ji Yun

AU - Lim, Sooyeon

AU - Song, Joon Young

AU - Choi, Won Suk

AU - Jeong, Hye Won

AU - Heo, Jung Yeon

AU - Lee, Jacob

AU - Seo, Yu Bin

AU - Lee, Jin Soo

AU - Wie, Seong Heon

AU - Kim, Young Keun

AU - Park, Kyung Hwa

AU - Jung, Sook In

AU - Kim, Shin Woo

AU - Lee, Sun Hee

AU - Lee, Han Sol

AU - Yoon, Young Hoon

AU - Cheong, Hee Jin

AU - Kim, Woo Joo

N1 - Funding Information: This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001) and by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (NRF- 2016R1A5A1010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

PY - 2017/5

Y1 - 2017/5

N2 - In the 2016-2017 season, the A(H3N2) influenza epidemic presented an unusual early peak pattern compared with past seasons in South Korea. The interim vaccine effectiveness (VE) of influenza vaccination in preventing laboratory-confirmed influenza was estimated using test-negative design through the tertiary hospital-based influenza surveillance system in South Korea. From 1 September, 2016 to 7 January, 2017, adjusted VE of influenza vaccination in preventing laboratory-confirmed A(H3N2) was -52.1% (95% confidence interval [CI], -147.2 to 6.4); -70.0% (95% CI, -212.0 to 7.4) in 19-64 years and 4.3% (95% CI, -137.8 to 61.5) in the elderly. Circulating A(H3N2) viruses belonged to the three phylogenetic subclades of 3C.2a, differently to A/Hong Kong/4801/2014, the current vaccine strain. Amino acid substitutions in hemagglutinin of circulating viruses seem to contribute to low VE. In conclusion, interim VE analysis presented that the protection of laboratory-confirmed influenza by seasonal influenza vaccination did not show the statistical significance in South Korea in the 2016-2017 influenza season.

AB - In the 2016-2017 season, the A(H3N2) influenza epidemic presented an unusual early peak pattern compared with past seasons in South Korea. The interim vaccine effectiveness (VE) of influenza vaccination in preventing laboratory-confirmed influenza was estimated using test-negative design through the tertiary hospital-based influenza surveillance system in South Korea. From 1 September, 2016 to 7 January, 2017, adjusted VE of influenza vaccination in preventing laboratory-confirmed A(H3N2) was -52.1% (95% confidence interval [CI], -147.2 to 6.4); -70.0% (95% CI, -212.0 to 7.4) in 19-64 years and 4.3% (95% CI, -137.8 to 61.5) in the elderly. Circulating A(H3N2) viruses belonged to the three phylogenetic subclades of 3C.2a, differently to A/Hong Kong/4801/2014, the current vaccine strain. Amino acid substitutions in hemagglutinin of circulating viruses seem to contribute to low VE. In conclusion, interim VE analysis presented that the protection of laboratory-confirmed influenza by seasonal influenza vaccination did not show the statistical significance in South Korea in the 2016-2017 influenza season.

UR - http://www.scopus.com/inward/record.url?scp=85019839557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019839557&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0178010

DO - 10.1371/journal.pone.0178010

M3 - Article

C2 - 28542417

AN - SCOPUS:85019839557

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0178010

ER -